Table 2. Grading scale, disease severity, and outcomes.
Mild | Moderate | Severe | Total | Pd | |
n | 8 | 24 | 17 | 49 | |
Bacteraemic a | 1 (13%) | 4 (17%) | 2 (12%) | 7 | NS |
Peak CRP b (units) | 46 [28-145] | 31 [6-58] | 49 (29-54) | - | NS |
Nadir albumin (g/dL) c | 33 [27-36] | 31 [22.5-34.5] | 26 (23-31) | - | NS |
ICU admission a | 1 (13%) | 2 (8%) | 2 (12%) | 5 | NS |
Required readmission d | 1 (13%) | 11 (46%) | 11 (65%) | 23 | 0.03 |
Length of stay (days) e , f | 13 [6-21] | 14 [11-17] | 15 [13-16) | NS | |
Doses of ivermectin e , f | 3 [3-3] | 5 [5-5] | 7 [7-7] | 0.001 |
n(%).
Highest plasma C-reactive protein during the hospital admission (median [IQR]).
Lowest serum albumin value during the hospital admission (median [IQR]).
P value for moderate and severe combined, compared with mild, except where indicated.
Median [IQR].
P value based on Kruskall Wallis test comparing the three groups.